6880
SHH:688089
Cabio Biotech (Wuhan) Co., Ltd.
- Stock
Last Close
25.01
30/04 07:00
Market Cap
2.25B
Beta: 0.47
Volume Today
2.96M
Avg: 1.23M
PE Ratio
27.75
PFCF: −7.01
Dividend Yield
2.76%
Payout:78.71%
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 66.01M - | 80.95M 22.63% | 92.43M 14.18% | 85.77M 7.21% | 73.03M 14.84% | 66.70M 8.68% | 65.67M 1.54% | 70.17M 6.85% | 78.17M 11.41% | 40.75M 47.88% | |
average payables | 11.35M - | 11.58M 2.08% | 10.25M 11.52% | 10.93M 6.63% | 15.64M 43.10% | 18.30M 17.03% | 21.66M 18.33% | 27.98M 29.19% | 69.38M 147.98% | 53.67M 22.65% | |
average receivables | 106.52M - | 106.68M 0.14% | 107.05M 0.35% | 117.70M 9.95% | 145.34M 23.48% | 168.97M 16.26% | 176.04M 4.18% | 199.90M 13.56% | 243.61M 21.86% | 133.26M 45.30% | |
book value per share | 5.24 - | 2.85 45.60% | 3.19 11.89% | 3.69 15.62% | 4.19 13.48% | 9.88 136.01% | 7.86 20.50% | 8.21 4.47% | 11.90 45.00% | ||
capex per share | -0.24 - | -0.17 26.01% | -0.13 26.37% | -0.18 43.24% | -0.10 46.53% | -0.18 87.74% | -0.20 7.09% | -1.03 422.39% | -2.09 103.00% | ||
capex to depreciation | -0.70 - | -0.83 18.07% | -0.59 28.06% | -0.86 44.47% | -0.44 48.36% | -0.80 81.17% | -1.27 58.42% | -7.24 468.86% | -9.24 27.65% | ||
capex to operating cash flow | -0.45 - | -0.49 7.67% | -0.26 46.64% | -0.23 11.23% | -0.12 49.48% | -0.18 51.74% | -0.23 28.63% | -1.68 640.04% | -1.41 15.77% | ||
capex to revenue | -0.11 - | -0.12 6.66% | -0.09 28.56% | -0.10 18.68% | -0.04 57.43% | -0.07 73.19% | -0.10 36.98% | -0.49 382.72% | -0.58 16.53% | ||
cash per share | 1.10 - | 0.13 87.95% | 0.35 167.72% | 0.60 70.09% | 0.97 61.25% | 6.69 588.33% | 5.13 23.23% | 4.02 21.71% | 4.42 10.05% | ||
days of inventory on hand | 254.43 - | 351.15 38.01% | 355.99 1.38% | 234.20 34.21% | 168.73 27.95% | 164.06 2.77% | 164.27 0.13% | 155.88 5.11% | 118.61 23.91% | ||
days payables outstanding | 40.21 - | 46.24 15.00% | 32.16 30.46% | 40.13 24.80% | 44.53 10.95% | 46.79 5.09% | 61.54 31.52% | 65.44 6.34% | 156.23 138.73% | ||
days sales outstanding | 213.21 - | 210.33 1.35% | 210.97 0.30% | 200.73 4.86% | 210.48 4.86% | 202.64 3.72% | 202.11 0.26% | 229.43 13.52% | 224.44 2.18% | ||
debt to assets | 0.02 - | 0.13 517.94% | 0.08 37.37% | 0.00 - | 0.02 1,128.83% | ||||||
debt to equity | 0.02 - | 0.17 604.26% | 0.10 40.40% | 0.00 - | 0.02 1,230.02% | ||||||
dividend yield | 0.00 - | 0.04 116,747.99% | 0.00 98.72% | 0.00 87.76% | 0.01 12,295.91% | 0.01 54.37% | 0.01 5.65% | 0.01 57.30% | 0.01 91.24% | ||
earnings yield | 0.01 - | 0.00 62.93% | 0.01 136.36% | 0.02 40.38% | 0.02 47.95% | 0.04 50.45% | 0.03 21.79% | 0.02 36.73% | 0.02 4.20% | ||
enterprise value | 2.84B - | 4.14B 45.76% | 4.17B 0.50% | 4.08B 1.94% | 4.02B 1.48% | 2.51B 37.53% | 3.90B 55.05% | 6.72B 72.46% | 3.40B 49.45% | ||
enterprise value over ebitda | 40.47 - | 80.24 98.27% | 41.29 48.54% | 36.96 10.48% | 31.63 14.42% | 14.57 53.94% | 20.64 41.67% | 37.97 83.98% | 21.03 44.62% | ||
ev to operating cash flow | 61.36 - | 92.97 51.51% | 66.61 28.35% | 40.58 39.08% | 37.91 6.58% | 19.05 49.74% | 26.72 40.24% | 65.08 143.57% | 19.26 70.40% | ||
ev to sales | 15.24 - | 22.88 50.08% | 21.94 4.08% | 17.87 18.57% | 14.07 21.29% | 8.07 42.63% | 12.05 49.34% | 19.14 58.88% | 7.84 59.05% | ||
free cash flow per share | 0.29 - | 0.18 35.62% | 0.37 98.75% | 0.61 67.68% | 0.75 21.47% | 0.86 15.31% | 0.67 21.86% | -0.42 162.00% | -0.61 47.02% | ||
free cash flow yield | 0.01 - | 0.01 35.62% | 0.01 98.75% | 0.02 67.68% | 0.02 21.47% | 0.03 43.02% | 0.02 26.55% | -0.01 139.96% | -0.02 99.34% | ||
graham net net | 1.94 - | 0.44 77.23% | 0.79 77.51% | 1.33 68.98% | 1.79 34.52% | 7.59 324.89% | 5.77 23.93% | 4.83 16.40% | 4.88 1.12% | ||
graham number | 7.07 - | 3.18 55.09% | 5.16 62.62% | 6.58 27.40% | 8.53 29.57% | 14.43 69.20% | 11.73 18.67% | 11.88 1.27% | 12.03 1.22% | ||
income quality | 1.23 - | 2.28 85.36% | 1.35 40.86% | 1.53 13.77% | 1.09 29.30% | 1.10 1.54% | 1.08 1.88% | 0.79 27.23% | 2.86 264.09% | ||
intangibles to total assets | 0.04 - | 0.04 9.37% | 0.06 38.70% | 0.05 10.47% | 0.04 17.54% | 0.01 73.16% | 0.01 4.59% | 0.01 13.62% | 0.02 148.40% | 0 100% | |
interest coverage | 54.38 - | 9.18 83.12% | 13.98 52.29% | 175.02 1,151.93% | -63.23 136.13% | 13.56K 21,544.78% | 333.37 - | 367.53 10.25% | |||
interest debt per share | 0.13 - | 0.49 267.12% | 0.34 31.48% | 0.00 99.31% | -0.01 541.20% | 0.00 100.82% | 0.02 - | 0.28 1,602.49% | |||
inventory turnover | 1.43 - | 1.04 27.54% | 1.03 1.36% | 1.56 52.00% | 2.16 38.80% | 2.22 2.85% | 2.22 0.13% | 2.34 5.38% | 3.08 31.42% | ||
invested capital | 0.02 - | 0.17 604.26% | 0.10 40.40% | 0.00 - | 0.02 1,230.02% | ||||||
market cap | 2.93B - | 4.10B 40.00% | 4.17B 1.66% | 4.16B 0.23% | 4.15B 0.34% | 3.36B 19.01% | 4.74B 41.30% | 7.38B 55.61% | 3.86B 47.74% | ||
net current asset value | 238.41M - | 135.70M 43.08% | 183.94M 35.55% | 249.77M 35.79% | 314.00M 25.72% | 1.05B 234.65% | 1.06B 1.24% | 928.17M 12.75% | 721.60M 22.26% | ||
net debt to ebitda | -1.23 - | 0.82 166.87% | -0.05 105.75% | -0.69 1,352.65% | -0.96 39.58% | -4.89 409.86% | -4.49 8.30% | -3.74 16.64% | -2.86 23.66% | ||
net income per share | 0.42 - | 0.16 62.93% | 0.37 136.36% | 0.52 40.38% | 0.77 47.95% | 0.94 21.30% | 0.78 16.79% | 0.76 1.83% | 0.54 29.35% | ||
operating cash flow per share | 0.52 - | 0.36 31.28% | 0.49 37.98% | 0.80 61.35% | 0.84 5.82% | 1.04 23.73% | 0.87 16.75% | 0.61 29.41% | 1.48 141.02% | ||
payables turnover | 9.08 - | 7.89 13.04% | 11.35 43.81% | 9.09 19.87% | 8.20 9.87% | 7.80 4.84% | 5.93 23.97% | 5.58 5.96% | 2.34 58.11% | ||
receivables turnover | 1.71 - | 1.74 1.37% | 1.73 0.30% | 1.82 5.10% | 1.73 4.63% | 1.80 3.87% | 1.81 0.26% | 1.59 11.91% | 1.63 2.23% | ||
research and ddevelopement to revenue | 0.08 - | 0.06 20.69% | 0.06 4.02% | 0.06 5.00% | 0.06 4.85% | 0.09 39.86% | 0.07 15.46% | ||||
return on tangible assets | 0.08 - | 0.05 39.99% | 0.10 125.61% | 0.14 31.07% | 0.17 27.29% | 0.09 47.09% | 0.10 3.66% | 0.09 6.14% | 0.04 54.36% | 0.06 38.71% | |
revenue per share | 2.10 - | 1.46 30.63% | 1.50 3.06% | 1.81 20.69% | 2.28 25.61% | 2.47 8.40% | 1.93 21.82% | 2.09 8.22% | 3.64 74.21% | ||
roe | 0.08 - | 0.06 31.85% | 0.12 111.25% | 0.14 21.42% | 0.18 30.37% | 0.09 48.61% | 0.10 4.67% | 0.09 6.03% | 0.05 51.27% | 0.06 36.65% | |
roic | 0.08 - | 0.03 63.39% | 0.06 108.53% | 0.09 46.16% | 0.13 42.18% | 0.10 25.50% | 0.08 18.19% | 0.07 9.41% | 0.07 0.11% | 0.05 30.97% | |
sales general and administrative to revenue | 0.18 - | 0.28 56.02% | 0.07 73.95% | 0.07 5.31% | 0.02 71.12% | 0.04 94.27% | 0.05 35.30% | 0.04 26.26% | 0.06 47.37% | ||
shareholders equity per share | 5.24 - | 2.85 45.60% | 3.19 11.89% | 3.69 15.62% | 4.19 13.48% | 9.88 136.01% | 7.86 20.50% | 8.21 4.47% | 11.90 45.00% | ||
stock based compensation to revenue | |||||||||||
tangible asset value | 447.30M - | 337.17M 24.62% | 376.09M 11.54% | 439.18M 16.78% | 502.34M 14.38% | 1.24B 145.90% | 1.31B 5.97% | 1.37B 4.56% | 1.39B 1.47% | 1.61B 16.20% | |
tangible book value per share | 5.03 - | 2.71 46.16% | 2.97 9.73% | 3.48 17.04% | 4.00 14.77% | 9.78 144.79% | 7.80 20.21% | 8.14 4.24% | 11.65 43.19% | ||
working capital | 241.38M - | 139.54M 42.19% | 191.75M 37.42% | 256.74M 33.89% | 319.18M 24.32% | 1.06B 231.27% | 1.07B 1.27% | 934.90M 12.69% | 726.92M 22.25% |
All numbers in CNY (except ratios and percentages)